Your browser doesn't support javascript.
loading
Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.
Ali, H Raza; Dariush, Aliakbar; Provenzano, Elena; Bardwell, Helen; Abraham, Jean E; Iddawela, Mahesh; Vallier, Anne-Laure; Hiller, Louise; Dunn, Janet A; Bowden, Sarah J; Hickish, Tamas; McAdam, Karen; Houston, Stephen; Irwin, Mike J; Pharoah, Paul D P; Brenton, James D; Walton, Nicholas A; Earl, Helena M; Caldas, Carlos.
Afiliação
  • Ali HR; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. raza.ali@cruk.cam.ac.uk.
  • Dariush A; Department of Pathology, University of Cambridge, Cambridge, UK. raza.ali@cruk.cam.ac.uk.
  • Provenzano E; Institute of Astronomy, University of Cambridge, Cambridge, UK. adariush@ast.cam.ac.uk.
  • Bardwell H; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. elena.provenzano@addenbrookes.nhs.uk.
  • Abraham JE; Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. elena.provenzano@addenbrookes.nhs.uk.
  • Iddawela M; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. elena.provenzano@addenbrookes.nhs.uk.
  • Vallier AL; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. helen.bardwell@cruk.cam.ac.uk.
  • Hiller L; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. ja344@medschl.cam.ac.uk.
  • Dunn JA; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. ja344@medschl.cam.ac.uk.
  • Bowden SJ; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. mahesh.iddawela@monash.edu.
  • Hickish T; Present address: Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. mahesh.iddawela@monash.edu.
  • McAdam K; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. Anne-Laure.Vallier@addenbrookes.nhs.uk.
  • Houston S; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK. Anne-Laure.Vallier@addenbrookes.nhs.uk.
  • Irwin MJ; Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. l.hiller@warwick.ac.uk.
  • Pharoah PD; Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. J.A.Dunn@warwick.ac.uk.
  • Brenton JD; Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham, UK. s.j.bowden@bham.ac.uk.
  • Walton NA; Royal Bournemouth Hospital and Bournemouth University, Castle Lane East, Bournemouth, UK. tamas.hickish@rbch.nhs.uk.
  • Earl HM; Peterborough and Stamford Hospitals NHS Foundation Trust and Cambridge University Hospital NHS Foundation Trust, Peterborough, UK. karen.mcadam@pbh-tr.nhs.uk.
  • Caldas C; Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK. shouston@nhs.net.
Breast Cancer Res ; 18(1): 21, 2016 Feb 16.
Article em En | MEDLINE | ID: mdl-26882907
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article